- VRTX +0.27%
Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know
Yahoo Finance · 2 days ago
Search results
Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases.
- 492.97Add to watchlist+1.35 (+0.27%)As of Thu. Jul 11, 2024 1:52 PM EDT · Nasdaq Real Time Price (USD) · Market open
- Open491.33High495.23Low489.01
- Mkt Cap127.21BP/E (TTM)32.03Div & YieldN/A & N/A
- Prev. Close491.6252 Wk. Low340.2052 Wk. High495.23
What analysts are sayingTop storiesRelated stocks
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
Jun 21, 2024 · Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease, and transfusion-dependent beta ...
Vertex Pharmaceuticals is focused on discovering, developing and producing innovative medicines so people with serious diseases can lead better lives.
2 days ago · Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients...
May 14, 2024 · Vertex Pharmaceuticals (NDAQ: VRTX) stands today as a top 20 pharma company with over a $100 billion market cap. But this biotech beacon has ridden a bumpy path to its current perch and, along...
Latest Press Releases. Jun 21 2024. Vertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific Sessions. Read More.
